Pediatric Primary Care Case Studies (149 page)

definitions for,
222
t

diagnosis of,
228

fundamental contexts of,
221
–223,
229

management of,
229

objectives for,
221

related health risk factors of,
221
,
223
–228

depression,
227
–228.
See also
depression (adolescents)

healthcare avoidance,
223
–224

mental health risks,
223

STDs,
221
,
223
,
226
–228

suicide risks,
227
–228

violence risks,
223
,
227
–228

resources for,
230

limp,
481
–492

case presentation for,
481
–483,
488
–491

diagnosis,
481
–488

diagnostic testing,
487
–488

differential,
484
–487

gait by chronological age,
484
t

history-taking,
481
–482

physical examination,
482
–483

symptom analyses,
482

transient synovitis,
489
–491

fundamental contexts for,
481
–482,
491

management of,
488
–491

educational plan,
489
–490

follow-up visits,
490
–491

medications,
490

objectives for,
481

resources for,
491
–492

Livostin.
See
levocabastine HCl (Livostin)

loratadine (Claritin),
343
t

loss of consciousness,
359
–376

case presentation for,
360
,
366
–368,
370
,
372
–373

diagnosis of,
363
–373

diagnostic testing,
363

ECGs,
370

emergent evaluations,
370
,
371
f

history-taking,
363
–367

imaging studies,
370

laboratory blood work,
369
–370

physical examinations,
367
–368

red flags,
364
–365

epidemiology/etiology of,
360
–361,
361
t

causal factors,
360
–361,
361
t

definitions,
360

recurrent episodes,
363

fundamental contexts of,
359
–360,
374

management of,
372
–373

best practice evidence,
372
–373

referral
vs
. admission indictors,
372

objectives for,
359

resources for,
374
–375

Luvox.
See
fluvoxamine (Luvox)

lymphoblastic leukemia,
486
–487

lymphoma,
305
–306

M

M-CHAT (Modified Checklist for Autism in Toddlers),
35
,
35
f

Macrodantin,
423

macrolides,
383
–384

management

of developmental problems

fatigue (adolescents),
66
–69

gross motor delays (infants),
21
–25

language/social delays (toddlers),
37
–39

of diseases

acne (adolescents),
471
–479

AD,
459
–464

anemia (toddlers),
313
–327

birth control (adolescents),
430
–439

cough,
383
–385

diarrhea/vomiting,
397
–400

fever,
242
–247

headache,
328
–332

late-preterm infants (well-child care),
501
–504

limp,
488
–491

oral trauma,
411
–414

overweight/high blood sugar,
270
t,
276
–284

recurrent ear infections (toddlers),
352
–356

red eye (preschoolers),
340
–344

short stature,
512
–516

syncope,
372
–373

urinary urgency/incontinence (preschoolers),
420
–425

vaginal discharge (adolescents),
449
–452

wheezing,
251
,
260
–264

of functional/mental health problems

abuse situations,
203
–204

ADHD,
182
–190

breastfeeding/slow weight gain (infants),
109
–111

constipation (school-age children),
124
t–125t,
126
–130,
129
t

depression (adolescents),
213
–219

LGBT issues,
229

overweight (preschoolers),
94
–95

PPEs,
152
–158,
152
t,
154
t–155t

sleep patterns (infants),
168
–172

mast cell stabilizers/antihistamines,
343
t

medications

for developmental problems

fatigue (adolescents),
68

language/social delays (toddlers),
37
–39

for diseases

acne (adolescents),
472
–473,
474
t–478t

AD,
459
–464

anemia (toddlers),
314
–315

asthma,
260